RELY Insider Filing: 10,000-Share Sale Planned; Recent 10b5-1 Sales Total 140,777

Rhea-AI Filing Summary

Remitly Global, Inc. (RELY) submitted a Form 144 reporting a proposed sale of 10,000 common shares under Rule 144, scheduled approximately for 08/14/2025, with an aggregate market value of $199,700. The filing shows these shares were acquired as founders shares on 11/04/2011. The issuer's reported shares outstanding are 206,193,217. The filer also disclosed multiple recent sales executed under a 10b5-1 sales plan during May–August 2025, totaling 140,777 common shares sold across several dates with combined gross proceeds reported per sale. The Form 144 includes the standard representation that the seller does not possess undisclosed material information.

Positive

• Transactions executed through a broker (Morgan Stanley Smith Barney), indicating formal transaction routing
• Use of a 10b5-1 sales plan for multiple recent sales, which demonstrates pre-authorized trading discipline

Negative

• Large cumulative insider sales in the past three months (140,777 shares) which were disclosed without context on remaining holdings
• Form does not specify dates of plan adoption or instruction, limiting transparency on timing relative to information access

Insights

Securities Analyst

TL;DR: Routine executive selling under Rule 144 and a 10b5-1 plan; transactions are documented but not materially transformative.

The filing documents a planned sale of 10,000 shares valued at $199,700 and confirms the shares were originally issued as founders shares in 2011. The disclosure of recent 10b5-1 sales totaling 140,777 shares over the past three months shows consistent execution of a trading plan rather than ad hoc sales. With reported outstanding shares of 206,193,217, the sizes disclosed are small in absolute percentage terms. The filing provides standard attestation regarding absence of nonpublic material information, and no additional operational or financial data about the issuer is included in this notice.

Corporate Governance Expert

TL;DR: Governance process followed: sales routed through broker, 10b5-1 plan usage disclosed, and standard seller attestation included.

The Form 144 shows use of Morgan Stanley Smith Barney LLC as the broker and identifies multiple executed 10b5-1 plan sales, indicating reliance on a pre-authorized trading arrangement. The filing includes the required representation that the seller is unaware of undisclosed material adverse information. There is no indication in this document of unusual insider trading patterns or conflicts, but the form does not provide plan adoption dates or the seller's remaining holdings, limiting deeper governance assessment.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	199700.00	206193217	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/04/2011	Founders Shares	Issuer			10000	11/04/2011	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for JOSHUA DAVID HUG 401 Union Street SEATTLE WA 98101	Common	08/07/2025	20000	381544.00
10b5-1 Sales Plan for JOSHUA DAVID HUG 401 Union Street SEATTLE WA 98101	Common	06/17/2025	10000	208877.00
10b5-1 Sales Plan for JOSHUA DAVID HUG 401 Union Street SEATTLE WA 98101	Common	06/16/2025	10000	194323.00
10b5-1 Sales Plan for JOSHUA DAVID HUG 401 Union Street SEATTLE WA 98101	Common	05/30/2025	20000	421488.00
10b5-1 Sales Plan for JOSHUA DAVID HUG 401 Union Street SEATTLE WA 98101	Common	05/29/2025	20000	427350.00
10b5-1 Sales Plan for JOSHUA DAVID HUG 401 Union Street SEATTLE WA 98101	Common	05/29/2025	40777	862009.47
10b5-1 Sales Plan for JOSHUA DAVID HUG 401 Union Street SEATTLE WA 98101	Common	05/16/2025	10000	228684.00
10b5-1 Sales Plan for JOSHUA DAVID HUG 401 Union Street SEATTLE WA 98101	Common	05/15/2025	10000	227713.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Remitly (RELY) report on this Form 144?

The filer reports a proposed sale of 10,000 common shares (aggregate market value $199,700) scheduled for 08/14/2025 under Rule 144.

How were the shares being sold originally acquired?

The 10,000 shares to be sold were acquired as founders shares on 11/04/2011 from the issuer.

Has the filer sold related shares recently?

Yes. The filing discloses multiple 10b5-1 plan sales during May–August 2025 totaling 140,777 common shares across several dates.

Which broker is handling the proposed sale?

The brokerage listed is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, New York, NY.

Does the filing indicate the seller has undisclosed material information?

By signing the notice the seller represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.